4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-038520
General Counsel and Secretary sold 16,256 shares at an average $28.12 ($457,077)
- General Counsel and Secretary acquired 16,256 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara General Counsel and Secretary | 2022-12-12 | Option exercise | +600 | $23.03 | $13,818 | 600 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-12 | Sale | −600 | $28.05 | $16,830 | 0 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-14 | Option exercise | +15,656 | $23.03 | $360,558 | 15,656 | D |
| Meisner Lara General Counsel and Secretary | 2022-12-14 | Sale | −15,656 | $28.12 | $440,247 | 0 | D |
| Derivatives | |||||||
| Meisner Lara General Counsel and Secretary | 2022-12-12 | Option exercise · Stock Option (Right to Buy) | −600 | 78,900 | D | ||
| Meisner Lara General Counsel and Secretary | 2022-12-14 | Option exercise · Stock Option (Right to Buy) | −15,656 | 63,244 | D | ||
| Open-market sales · 16,256 sh · avg $28.12 · $457,077 | |||||||
Loading xslF345X03/doc4.xml…